This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Max Biopharma, Inc., University of California. Active years: 2017-2025.
Location History:
- Rosemead, CA (US) (2017)
- Los Angeles, CA (US) (2020)
Company Filing History:
Years Active: 2017-2025
Title: Yi Chiao Fan: Innovator in Cardiac and Hedgehog Signaling Research
Introduction
Yi Chiao Fan is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the fields of cardiac rhythmicity and Hedgehog signaling. With a total of 3 patents, his work has the potential to impact various medical treatments.
Latest Patents
Yi Chiao Fan's latest patents include innovative approaches to regulating cardiac rhythmicity. His first patent focuses on anti-arrhythmicity agents, detailing agents, compositions, and methods for regulating cardiac rhythmicity. The second patent addresses oxysterols and Hedgehog signaling, describing compounds and pharmaceutical compositions that inhibit Hedgehog signaling. This patent also outlines methods for using these inhibitors, either alone or in combination with other compounds, to treat diseases or conditions that would benefit from the inhibition of Hedgehog signaling.
Career Highlights
Throughout his career, Yi Chiao Fan has worked with notable organizations such as Max Biopharma, Inc. and the University of California. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Some of his notable coworkers include Frank Stappenbeck and Feng Wang. Their collaboration has likely contributed to the advancement of research in their respective fields.
Conclusion
Yi Chiao Fan's contributions to cardiac and Hedgehog signaling research highlight his role as an influential inventor. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.